Nectero Medical Stock

Nectero Medical is a biotechnology company that focuses on developing treatments intended for aneurysmal disease, which is a condition that causes patients to suffer from aneurysms. The company’s flagship product is the Nectero Endovascular Aneurysm Stabilization Treatment (Nectero EAST®) System. Nectero EAST is designed for aneurysm management, particularly for small to medium-sized abdominal aortic aneurysms (AAA). It is an investigational system that strives to deliver pentagalloyl glucose directly into the aneurysmal wall with the goal of offering patients a minimally invasive alternative to traditional treatments.